Cannabinoids as Antioxidants and Neuroprotectants, Exclusive license US Patent 66305071-10 Employees
- B2C
- Early StageStartup in initial stages
- Recently fundedRaised funding in the past six months
- Website
- Company size
- 1-10 people
- Total raised
- $1.5M
- Markets
KannaLife Sciences Funding
$1.5M
11 round
Funding Rounds
A
$1,500,000